Literature DB >> 16151548

Long-term follow-up of trigger point injections for abdominal wall pain.

Jose Nazareno1, Terry Ponich, Jamie Gregor.   

Abstract

OBJECTIVE: Abdominal wall pain (AWP) is a common yet often overlooked source of abdominal pain. Trigger point injections (TPI) into the abdominal wall have been tried in the past. Few studies have looked at the long-term outcome from these injections.
METHODS: A retrospective chart review was performed on 110 consecutive patients who received TPI for abdominal pain at the University of Western Ontario, London, Ontario. Outcomes from patients whose pain was due to AWP were determined. AWP was defined as fixed or localized pain and superficial or point tenderness (less than 2.5 cm diameter) or a positive Carnett sign (increased pain with tensing abdomen). The primary outcome was long-term efficacy of TPI. The number of diagnostic tests ordered to exclude AWP and the cost of investigating it were determined. Secondary analyses were done to determine if there were significant predictors of response to TPI.
RESULTS: Eighty-nine of 110 patients who received TPI met the criteria for AWP. In those who met the criteria for AWP, the average age was 42 years, 84% were female, and the average length of follow-up was 25 months. The primary outcome shows that, at follow-up, 77% had some or complete relief and 23% had no relief. An average of 4.3 diagnostic tests per patient were ordered to exclude other causes of abdominal pain. Secondary analyses show that meeting the criteria for AWP (P<0.0005), the absence of gastrointestinal symptoms (P<0.025), and an upper abdominal location of pain (P<0.025) were statistically significant predictors of a positive response to TPI.
CONCLUSIONS: This study demonstrates that TPI, in patients who meet criteria for AWP, are effective over the long term.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16151548     DOI: 10.1155/2005/274181

Source DB:  PubMed          Journal:  Can J Gastroenterol        ISSN: 0835-7900            Impact factor:   3.522


  8 in total

1.  Carnett's Legacy: Raising Legs and Raising Awareness of an Often Misdiagnosed Syndrome.

Authors:  George F Longstreth
Journal:  Dig Dis Sci       Date:  2016-02       Impact factor: 3.199

2.  Thoracic disk herniation, a not infrequent cause of chronic abdominal pain.

Authors:  F J Pérez Lara; A Ferrer Berges; J Quintero Quesada; J A Moreno Ramiro; R Bustamante Toledo; H Oliva Muñoz
Journal:  Int Surg       Date:  2012 Jan-Mar

Review 3.  Anterior cutaneous nerve entrapment syndrome (ACNES).

Authors:  M R Scheltinga; R M Roumen
Journal:  Hernia       Date:  2017-12-21       Impact factor: 4.739

4.  Effect of Acupuncture on Chronic Pelvic Pain Secondary to Abdominal Myofascial Syndrome Not Responsive to Local Anesthetic Block: A Pilot Study.

Authors:  Andréia Moreira de Souza Mitidieri; Maria Beatriz Ferreira Gurian; Ana Paula Moreira da Silva; Omero Benedicto Poli-Neto; Antônio Alberto Nogueira; Francisco José Candido-Dos-Reis; Júlio César Rosa-E-Silva
Journal:  Med Acupunct       Date:  2017-12-01

5.  Myofacial Trigger Points in Advanced Cancer Patients.

Authors:  Hideaki Hasuo; Tatsuhiko Ishihara; Kenji Kanbara; Mikihiko Fukunaga
Journal:  Indian J Palliat Care       Date:  2016 Jan-Mar

6.  Anaesthetic injection versus ischemic compression for the pain relief of abdominal wall trigger points in women with chronic pelvic pain.

Authors:  Mary L L S Montenegro; Carolina A Braz; Julio C Rosa-e-Silva; Francisco J Candido-dos-Reis; Antonio A Nogueira; Omero B Poli-Neto
Journal:  BMC Anesthesiol       Date:  2015-12-01       Impact factor: 2.217

7.  Construction and validation of a questionnaire distinguishing a chronic abdominal wall pain syndrome from irritable bowel syndrome.

Authors:  Tijmen van Assen; Oliver B Boelens; Jan T Kamphuis; Marc R Scheltinga; Rudi M Roumen
Journal:  Frontline Gastroenterol       Date:  2012-07-26

8.  Sonography-guided trigger point injections in abdominal myofascial pain syndrome.

Authors:  Hye Chang Rhim; Jae Hyun Cha; Jaehyung Cha; Dong Hwee Kim
Journal:  Medicine (Baltimore)       Date:  2020-12-04       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.